Breaking News Instant updates and real-time market news.

SAVE

Spirit Airlines

$42.88

0.64 (1.52%)

, EADSY

Airbus

$15.07

0.19 (1.28%)

10:02
10/11/16
10/11
10:02
10/11/16
10:02

Spirit Airlines says first American carrier to receive Airbus A320neo

Spirit Airlines (SAVE) said it became the first American carrier to receive the Airbus (EADSY) A320neo this week, a state-of-the-art aircraft powered by the Pratt & Whitney (UTX) PurePower Geared Turbofan. Spirit is set to add five Airbus A320neos to its network by the end of the year.

SAVE

Spirit Airlines

$42.88

0.64 (1.52%)

EADSY

Airbus

$15.07

0.19 (1.28%)

UTX

United Technologies

$99.60

-0.38 (-0.38%)

  • 25

    Oct

SAVE Spirit Airlines
$42.88

0.64 (1.52%)

09/29/16
IMPC
09/29/16
INITIATION
Target $51
IMPC
Outperform
Spirit Airlines initiated with an Outperform at Imperial Capital
Imperial Capital analyst Michael Derchin started Spirit Airlines with an Outperform rating and $51 price target.
08/04/16
08/04/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Texas Instruments (TXN) upgraded to Neutral from Underperform at Exane BNP Paribas. 2. Spirit Airlines (SAVE) upgraded to Strong Buy from Outperform at Raymond James with analyst Savanthi Syth saying the recent weakness in the shares brings a "very attractive entry point." 3. Archer Daniels (ADM) upgraded to Buy from Hold at Argus with analyst David Coleman citing valuation and management's optimistic outlook for the second half of 2016. 4. Celgene (CELG) upgraded to Buy from Neutral at BTIG. Analyst Dane Leone believes the company's 2020 financial targets are achievable and represent upside to current consensus estimates. 5. Apollo Global (APO) upgraded to Outperform from Perform at Oppenheimer and to Outperform from Market Perform at Keefe Bruyette. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/04/16
RAJA
08/04/16
UPGRADE
Target $59
RAJA
Strong Buy
Spirit Airlines upgraded to Strong Buy from Outperform at Raymond James
Raymond James analyst Savanthi Syth upgraded Spirit Airlines to Strong Buy saying the recent weakness in the shares brings a "very attractive entry point." The analyst admits there is a lack of near-term catalysts and that Zika is likely to remain a headline risk, however. Syth has a $59 price target for the shares.
08/04/16
RAJA
08/04/16
UPGRADE
RAJA
Strong Buy
Spirit Airlines upgraded to Strong Buy from Outperform at Raymond James
EADSY Airbus
$15.07

0.19 (1.28%)

07/25/16
JPMS
07/25/16
DOWNGRADE
JPMS
Underweight
Airbus downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst David Perry downgraded Airbus Group downgraded to Underweight citing "ongoing execution risks and deteriorating airline news." The analyst cut his price target for the shares to EUR 45.5 from EUR 51.
05/09/16
GSCO
05/09/16
UPGRADE
GSCO
Buy
Airbus upgraded to Buy from Neutral at Goldman
Goldman Sachs analyst Chris Hallam upgraded Airbus to Buy from Neutral ahead of the company's first half earnings on July 27, citing "an improvement in order momentum or clarification on technical issues that affect A350 interiors, A320neo engines and A400M engines" as potential upside catalysts.
04/29/16
BERN
04/29/16
NO CHANGE
BERN
Airbus should be bought on weakness, says Bernstein
Bernstein says that Airbus' Q1 results reflect previously disclosed bad news, including the downturn in deliveries. The firm still expects the company's earnings growth to accelerate as it increases production of profitable planes. Moreover, the firm remains upbeat on the company's outlook from 2017 onward. Bernstein keeps an Outperform rating on the shares.
04/05/16
BERN
04/05/16
NO CHANGE
BERN
Airbus named to Best of Bernstein list at Bernstein
Bernstein named Airbus to its Best of Bernstein list for European Aerospace & Defense. The firm says that the company should benefit from healthy demand for commercial aircraft, while its new A350 program has exceeded expectations and has "proceeded...better than any new aircraft program in the last 30 years." Bernstein thinks that the stock's valuation is attractive, and it keeps an Outperform rating on the shares.
UTX United Technologies
$99.60

-0.38 (-0.38%)

10/10/16
10/10/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Honeywell (HON) downgraded to Buy from Conviction Buy at Goldman with analyst Christopher Glynn lowering his Q3 Earnings Per Share expectations for Honeywell after the company cut its earnings and revenue outlook and trimmed his price target to $122 from $128. 2. United Technologies (UTX) downgraded to Neutral from Buy at Citi with analyst Jason Gursky saying he sees three issues limiting share upside over the next twelve-plus months. 3. PNC Financial (PNC) was downgraded to Neutral from Buy at Nomura while the firm downgraded Fifth Third (FITB) to Reduce from Neutral. 4. Myriad Genetics (MYGN) downgraded to Sell from Neutral at Ladenburg with analyst Kevin DeGeeter citing a "significant and unexpected deterioration" in outlook for the company's companion diagnostic franchise. 5. HSN, Inc. (HSNI) downgraded to Hold from Buy at Craig-Hallum with analyst Alex Fuhrman saying his channel checks indicate continued weakness in the third quarter, with particular weakness in jewelry and consumer electronics. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/10/16
SBSH
10/10/16
DOWNGRADE
Target $109
SBSH
Neutral
United Technologies downgraded to Neutral from Buy at Citi
Citi analyst Jason Gursky downgraded United Technologies to Neutral saying he sees three issues limiting share upside over the next twelve-plus months. Gursky believes 2017 consensus estimates are too high and that management is likely to reduce its 2020 targets at March's annual investor day. Further, he highlights manufacturing issues on the new GTF engine. The analyst cut his price target for the shares to $109 from $115.
05/03/16
05/03/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. ACADIA (ACAD) downgraded to Market Perform at Leerink by analyst Paul Matteis, who said his 2016-2018 revenue estimates are below consensus. The analyst said that consensus estimates for the pimavanserin launch "may overlook a collection of minor headwinds." He admits that ACADIA could be attractive to multiple potential buyers, including Biogen (BIIB) and Amgen (AMGN).2. Sarepta (SRPT) downgraded to Underperform at Leerink with analyst Joseph Schwartz believing the FDA's interpretation of empirical data for eteplirsen will be consistent with the recent negative panel, which was critical despite powerful human testimonies. 3. Community Health (CYH) downgraded to Underperform at BofA/Merrill by analyst Kevin Fischbeck, who said Q1 was disappointing. The analyst does not see volumes accelerating and is skeptical the company can turn around HMA assets in the near-term enough to hit margin targets. 4. United Technologies (UTX) downgraded to Sector Perform at RBC Capital because the firm says that Honeywell's (HON) actions indicate that it's no longer interested in buying United Technologies. The firm also said that Honeywell hasn't looked to increase the amount of cash it returns to shareholders. 5. On Deck Capital (ONDK) downgraded to Underperform at Sterne Agee CRT, to Hold at Canaccord and Needham, and to Neutral at BTIG following its weaker than expected Q1 results and guidance cut. Canaccord analyst Michael Graham said tepid originations growth raises concerns regarding borrowing demand and sees increased uncertainties cropping up. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/16
BARD
10/06/16
INITIATION
Target $110
BARD
Neutral
United Technologies initiated with a Neutral at Baird
Baird analyst Peter.Arment initiated United Technologies with a Neutral and a $110 price target.

TODAY'S FREE FLY STORIES

AKBA

Akebia

$17.90

0.33 (1.88%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Hot Stocks
Breaking Hot Stocks news story on Akebia »

Akebia: Phase 2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AXON

Axovant Sciences

$24.25

-0.74 (-2.96%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Hot Stocks
Breaking Hot Stocks news story on Axovant Sciences »

Axovant announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$83.14

0.26 (0.31%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Earnings
Darden backs FY18 adjusted cont ops EPS view $4.38-$4.50, consensus $4.47 »

The company reaffirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AKBA

Akebia

$17.90

0.33 (1.88%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Hot Stocks
Breaking Hot Stocks news story on Akebia »

Akebia: Phase 3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AKBA

Akebia

$17.90

0.33 (1.88%)

07:01
09/26/17
09/26
07:01
09/26/17
07:01
Hot Stocks
Akebia saya Phase 2 vadadustat study confirmed findings from previous studies »

Akebia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

07:00
09/26/17
09/26
07:00
09/26/17
07:00
General news
FX Update: The dollar has been in rally mode »

FX Update: The dollar has…

DIS

Disney

$99.57

0.97 (0.98%)

06:59
09/26/17
09/26
06:59
09/26/17
06:59
Periodicals
Disney streams theme-park events in new prototype stores, Bloomberg says »

Walt Disney is opening…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

SPX

S&P 500

06:59
09/26/17
09/26
06:59
09/26/17
06:59
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LCI

Lannett

$17.10

-0.3 (-1.72%)

06:58
09/26/17
09/26
06:58
09/26/17
06:58
Hot Stocks
Lannett revceives approval for Dexmethylphenidate Hydrochloride Tablets »

Lannett announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDX

Market Vector Gold Miners

$23.83

0.36 (1.53%)

06:58
09/26/17
09/26
06:58
09/26/17
06:58
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$124.53

1.29 (1.05%)

06:58
09/26/17
09/26
06:58
09/26/17
06:58
Technical Analysis
SPDR Gold Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXON

Axovant Sciences

$24.25

-0.74 (-2.96%)

06:58
09/26/17
09/26
06:58
09/26/17
06:58
Hot Stocks
Breaking Hot Stocks news story on Axovant Sciences »

Axovant Sciences trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUGT

Direxion Gold Miners Bull

$35.50

1.72 (5.09%)

06:57
09/26/17
09/26
06:57
09/26/17
06:57
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$20.07

1 (5.24%)

06:57
09/26/17
09/26
06:57
09/26/17
06:57
Technical Analysis
Direxion Daily Jr Gld Mnrs Bull 3X Shrs: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUST

Direxion Daily Gold Miners Bear 3X ETF

$23.21

-1.2 (-4.92%)

06:57
09/26/17
09/26
06:57
09/26/17
06:57
Technical Analysis
Direxion Daily Gold Miners Bear 3X ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$50.66

-2.87 (-5.36%)

06:56
09/26/17
09/26
06:56
09/26/17
06:56
Technical Analysis
Direxion Daily Junior Gold Miners Index Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VXX

iPath S&P 500 VIX Short-Term Futures

$41.28

0.03 (0.07%)

06:56
09/26/17
09/26
06:56
09/26/17
06:56
Technical Analysis
iPath S&P 500 VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XIV

VelocityShares Daily Inverse VIX Short-Term ETN

$92.69

-0.14 (-0.15%)

06:55
09/26/17
09/26
06:55
09/26/17
06:55
Technical Analysis
VelocityShares Daily Inverse VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVIX

VelocityShares Daily 2x VIX Short-Term ETN

$12.60

0.06 (0.48%)

06:55
09/26/17
09/26
06:55
09/26/17
06:55
Technical Analysis
VelocityShares Daily 2x VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYE

Myers Industries

$19.70

-0.3 (-1.50%)

06:55
09/26/17
09/26
06:55
09/26/17
06:55
Syndicate
Breaking Syndicate news story on Myers Industries »

Myers Industries files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVXY

ProShares Short VIX Short-Term Futures

$89.07

-0.04 (-0.04%)

06:55
09/26/17
09/26
06:55
09/26/17
06:55
Technical Analysis
ProShares Short VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXMD

TherapeuticsMD

$6.06

-0.11 (-1.78%)

06:54
09/26/17
09/26
06:54
09/26/17
06:54
Syndicate
TherapeuticsMD 12.4M share Spot Secondary priced at $5.65 »

JPMorgan acted as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Nov

  • 26

    Sep

MB

Mindbody

$26.10

-0.8 (-2.97%)

06:54
09/26/17
09/26
06:54
09/26/17
06:54
Conference/Events
Mindbody to host analyst day »

Analyst day to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

USO

United States Oil Fund

$10.55

0.31 (3.03%)

06:53
09/26/17
09/26
06:53
09/26/17
06:53
Technical Analysis
United States Oil Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBRA

Sabra Health Care

$22.33

0.12 (0.54%)

06:53
09/26/17
09/26
06:53
09/26/17
06:53
Syndicate
Sabra Health Care 16M share Spot Secondary priced at $21.00 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.